Table 1 Patients’ characteristics
Total | 79 |
Age (years) | |
Mean ± SD; range | 58.9 ± 13.4; 27–84 |
Median | 61 |
Gender (male) | 47 (60%) |
Myasthenia gravis | 15 (19%) |
MGFA class I | 13 |
MGFA class IIa | 1 |
MGFA class IIb | 1 |
Neoadjuvant therapy | 3 (4%) |
Chemotherapy | 2 |
Chemo-radiotherapy | 1 |
Adjuvant radiotherapy | 47 (60%) |
Surgical approach | |
Median sternotomy | 65 (82%) |
Thoracotomy | 4 (5%) |
VATS | 10 (13%) |
Surgical procedure | |
Complete thymectomy | 64 (81%) |
Extended thymectomy | 15 (19%) |
WHO classification | |
A | 5 (6%) |
AB | 32 (41%) |
B1 | 16 (20%) |
B2 | 11 (14%) |
B3 | 15 (19%) |
Masaoka-Koga stage | |
I | 21 (27%) |
II | 41 (52%) |
III | 16 (20%) |
IV | 1 (1%) |
TNM stage | |
I | 65 (82%) |
II | 2 (3%) |
IIIA | 11 (14%) |
IIIB | 1 (1%) |